Last reviewed · How we verify
PPC-5650
At a glance
| Generic name | PPC-5650 |
|---|---|
| Also known as | No other name |
| Sponsor | Aros Pharma ApS |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Investigation of Efficacy and Safety of PPC-5650 to Experimental Induced Sensation and Pain in the Rectosigmoid (PHASE1)
- A Study of Local Effect and Safety of a Single PPC-5650 Dose on Reflux Pain During Pain Stimulation in the Esophagus (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PPC-5650 CI brief — competitive landscape report
- PPC-5650 updates RSS · CI watch RSS
- Aros Pharma ApS portfolio CI